Abstract
Reciprocal interactions between central 5-HT system and hypothalamo-pituitary-adrenal (HPA) axis are of particular relevance with regard to depression, in which alterations of both systems have been evidenced. In order to further explore these interactions, two models of mutant mice have been used. They consisted of knock-out mice lacking the 5-HT transporter (5-HTT−/−) and of transgenic mice with impaired glucocorticoid receptor (GR-i) expression. Under control conditions, the functional properties of 5-HT1A autoreceptors in GR-i mice were as in their paired wild-type. However, both chronic stress and long term treatment with fluoxetine induced abnormal adaptive changes in 5-HT1A autoreceptor functioning in GR-i mice. On the other hand, a marked desensitization of 5-HT1A autoreceptors was found in 5-HTT−/− mice as compared with paired wild-type animals, and this phenomenon was further enhanced by exposure to stressful conditions. These data show that alterations of HPA axis at the gene level has consequences on 5-HT neurotransmission, and reciprocally, that 5-HTT knock-out affects HPA-dependent responses to stress.
Similar content being viewed by others
REFERENCES
Chaouloff, F. 1993. Physiopharmacological interactions between stress hormones and central serotoninergic systems. Brain Res. Rev. 18:1-32.
Azmitia, E. C., Liao, B., and Chen, Y. S. 1993. Increase of tryptophan hydroxylase enzyme protein by dexamethasone in adrenalectomized rat midbrain. J. Neurosci. 13:5041-5055.
Holmes, M. C., French, K. L., and Seckl, J. R. 1997. Dysregulation of diurnal rhythms of serotonin 5-HT2C and corticosteroid receptor gene expression in the hippocampus with food restriction and glucocorticoids. J. Neurosci. 17:4056-4065.
Maes, M. and Meltzer, H. 1995. The serotonin hypothesis of major depression. Pages 933-944. In: Bloom, F., and Kupfer, D. (Eds), Psychopharmacology: the Fourth Generation of Progress. Raven Press, New York.
Montgomery, S. A., Dufour, H., Brion, S., Gailledreau, J., Laqueille, X., Ferrey, G., Moron, P., Parant-Lucena, N., Singer, L., Danion, J. M. et al. 1988. The prophylactic efficacy of fluoxetine in unipolar depression. Br. J. Psychiatry Suppl. 3:69-76.
Bengel, D., Murphy, D. L., Andrews, A. M., Wichems, C. H., Feltner, D., Heils, A., Mössner, R., Westphal, H., and Lesch, K. P. 1998. Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine (“ecstasy”) in serotonin transporter-deficient mice. Mol. Pharmacol. 53:649-655.
Fabre, V., Beaufour, C., Evrard, A., Rioux, A., Hanoun, N., Lesch, K. P., Murphy, D. L., Lanfumey, L., Hamon, M., and Martres, M. P. 2000. Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. Eur. J. Neurosci. 12:2299-2310.
Li, Q., Wichems, C., Heils, A., Van De Kar, L. D., Lesch, K. P., and Murphy, D. L. 1999. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice. J. Pharmacol. Exp. Ther. 291:999-1007.
Mannoury la Cour, C., Palazzo, E., Lesch, K. P., Hamon, M., and Lanfumey, L. 1998. Functional adaptation of 5-HT1A receptors in mice lacking the 5-HT transporter. 1998, Soc. Neurosci. 24:1113.
Rioux, A., Fabre, V., Lesch, K. P., Moessner, R., Murphy, D. L., Lanfumey, L., Hamon, M., and Martres, M. P. 1999. Adaptive changes of serotonin 5-HT1A receptors in mice lacking the serotonin transporter. Neurosci. Lett. 262:113-116.
Pepin, M. C., Pothier, F., and Barden, N. 1992. Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene. Nature 355:725-728.
Montkowski, A., Barden, N., Wotjak, C., Stec, I., Ganster, J., Meaney, M., Engelmann, M., Reul, J. M., Landgraf, R., and Holsboer, F. 1995. Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function. J. Neuroendocrinol. 7:841-845.
Barden, N., Stec, I. S., Montkowski, A., Holsboer, F., and Reul, J. M. 1997. Endocrine profile and neuroendocrine challenge tests in transgenic mice expressing antisense RNA against the glucocorticoid receptor. J. Neuroendocrinol. 66:212-220.
Blier, P. and de Montigny, C. 1994. Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15:220-226.
Hamon, M. 1997. The main features of central 5-HT1A receptors. In: Serotoninergic neurons and 5-HT receptors in the CNS. Pages 239-268. In: Baumgarten, H. G., and Göthert, M. (Eds), Handbook of Experimental Pharmacology, Vol. 129. Springer-Verlag, Berlin, Heidelberg.
Le Poul, E., Laaris, N., Doucet, E., Laporte, A. M., Hamon, M., and Lanfumey, L. 1995. Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn-Schmiedebergs Arch. Pharmacol. 352:141-148.
Le Poul, E., Boni, C., Hanoun, N., Laporte, A. M., Laaris, N., Chauveau, J., Hamon, M., and Lanfumey, L. 2000. Differential adaptation of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacol. 39:110-122.
Laaris, N., Haj-Dahmane, S., Hamon, M., and Lanfumey, L.1995. Glucocorticoid receptor-mediated inhibition by corticosterone of 5-HT1A autoreceptor functioning in the rat dorsal raphe nucleus. Neuropharmacol. 34:1201-1210.
Laaris, N., Le Poul, E., Laporte, A. M., Hamon, M., and Lanfumey, L. 1999. Differential effects of stress on presynaptic and postsynaptic 5-hydroxytryptamine-1A receptors in the rat brain: an in vitro electrophysiological study. Neuroscience 91:947-958.
Lanfumey, L., Pardon, M. C., Laaris, N., Joubert, C., Hanoun, N., Hamon, M., and Cohen-Salmon, C. 1999. 5-HT1A autoreceptor desensitization by chronic ultramild stress in mice. NeuroReport 10:3369-3374.
Lesch, K. P. 1997. Molecular biology, pharmacology, and genetics of the serotonin transporter: Psychobiological and clinical implications. In: Serotoninergic neurons and 5-HT receptors in the CNS. Pages 671-705. In: Baumgarten, H. G., and Göthert, M. (Eds), Handbook of Experimental Pharmacology, Vol. 129, Springer-Verlag, Berlin, Heidelberg.
Barker, E. L. and Blakely, R. D. 1995. Norepinephrine and serotonin transporters; molecular targets of antidepressant drugs. Pages 321-333. In: Bloom, F., and Kupfer, D. (Eds), Psychopharmacology: the Fourth Generation of Progress. Raven Press, New York.
Chang, A. S., Chang, S. M., Starnes, D. M., Schroeter, S., Bauman, A. L., and Blakely, R. D. 1996. Cloning and expression of the mouse serotonin transporter. Mol. Brain Res. 43:185-192.
Pardon, M. C., Perez-Diaz, F., Joubert, C., and Cohen-Salmon, C. 2000. Influence of a chronic ultramild stress procedure on decision-making in mice. J. Psychiatry Neurosci. 25:167-177.
Froger, N., Palazzo, E., Cohen-Salmon, C., Lesch, K. P., Barden, N., Hamon, M., and Lanfumey, L. 1999. Interactions entre le systè me sérotoninergique et l'axe hypothalamo-hypophyso-surrénalien dans des modè les transgéniques. In: 4è me Coll. Soc. Neurosci., Marseille, Mai 1999, Abstract Book pp. 210.
Naranjo, C. A., Poulos, C. X., Bremner, K. E., and Lanctot, K. L. 1994. Fluoxetine attenuates alcohol intake and desire to drink. Int. Clin. Psychopharmacol. 9:163-172.
Maurel, S., De Vry, J., and Schreiber, R. 1999. Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvoxamine in alcoholpreferring cAA rats. Alcohol 17:195-201.
Hammoumi, S., Payen, A., Favre, J. D., Balmes, J. L., Benard, J. Y., Husson, M., Ferrand, J. P., Martin, J. P., and Daoust, M.1999. Does the short variant of the serotonin transporter linked polymorphic region constitute a marker of alcohol dependence? Alcohol 17:107-112.
Sander, T., Harms, H., Dufeu, P., Kuhn, S., Hoehe, M., Lesch, K. P., Rommelspacher, H., and Schmidt, L. G. 1998. Serotonin transporter gene variants in alcohol-dependent subjects with dissocial personality disorder. Biol. Psychiatry 43:908-912.
Crabbe, J. C., Phillips, T. J., Feller, D. J., Hen, R., Wenger, C. D., Lessov, C. N., and Schafer, G. L. 1996. Elevated alcohol consumption in null mutant mice lacking 5-HT1B serotonin receptors. Nat. Genet. 14:98-101.
Haraguchi, M., Samson, H. H., and Tolliver, G. A., 1990. Reduction of oral ethanol self-administration in the rat by the 5-HT uptake blocker fluoxetine. Pharmacol. Biochem. Behav. 35:259-262.
Deakin, J. F., Pennell, I., Upadhyaya, A. J., and Lofthouse, R.1990. A neuroendocrine study of 5-HT function in depression: evidence for biological mechanisms of endogenous and psychosocial causation. Psychopharmacol. 101:85-92.
Lesch, K. P., Mayer, S., Disselkamp-Tietze, J., Hoh, A., Wiesmann, M., Osterheider, M., and Schulte, H. M. 1990. 5-HT1A receptor responsivity in unipolar depression. Evaluation of ipsapirone-induced ACTH and cortisol secretion in patients and controls. Biol. Psychiatry 28:620-628.
Linthorst, A. C., Flachskamm, C., Barden, N., Holsboer, F., and Reul, J. M. 2000. Glucocorticoid receptor impairment alters CNS responses to a psychological stressor: an in vivo microdialysis study in transgenic mice. Eur. J. Neurosci. 12:283-291.
Farisse, J., Boulenguez, P., Semont, A., Héry, F., Barden, N., Faudon, M., and Héry, M. 1999. Regional serotonin metabolism under basal and restraint stress conditions in the brain of transgenic mice with impaired glucocorticoid receptor function. Neuroendocrinol. 70:413-421.
Barden, N. 1996. Modulation of glucocorticoid receptor gene expression by antidepressant drugs. Pharmacopsychiatry 29:12-22.
Barden, N. 1999. Regulation of corticosteroid receptor gene expression in depression and antidepressant action. J. Psychiatry Neurosci. 24:25-39.
Smeraldi, E., Zanardi, R., Benedetti, F., Di Bella, D., Perez, J., and Catalano, M. 1998. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol. Psychiatry 3:508-511.
Holsboer, F. and Barden, N. 1996. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr. Rev. 17:187-205.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lanfumey, L., La Cour, C.M., Froger, N. et al. 5-HT-HPA Interactions in Two Models of Transgenic Mice Relevant to Major Depression. Neurochem Res 25, 1199–1206 (2000). https://doi.org/10.1023/A:1007683810230
Issue Date:
DOI: https://doi.org/10.1023/A:1007683810230